Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-29 @ 2:33 PM
Study NCT ID:
NCT03872232
Status:
COMPLETED
Last Update Posted:
2021-01-15
First Post:
2019-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
Sponsor:
Addpharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-12
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-11
First Submit QC Date:
None
Study First Post Date:
2019-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-13
Last Update Post Date:
2021-01-15
Last Update Post Date Type:
ACTUAL